Sustained improvement of diffuse systemic sclerosis following human cytomegalovirus infection offers insight into pathogenesis and therapy.
Pia
P
Moinzadeh
Korsa
K
Khan
Voon H
VH
Ong
Christopher P
CP
Denton
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000276:immunology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012075:Remission, Spontaneous; D045743:Scleroderma, Diffuse / Q000188:drug therapy / Q000276:immunology / Q000821:virology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009173:Mycophenolic Acid